Obiettivo
The current test systems employed by Industry are poorly predictive for Drug induced liver injury (DILI). The ‘MIP-DILI’ project will address this situation by the development of innovative preclinical test systems which are both mechanism-based and of physiological, pharmacological and pathological relevance to DILI in humans. An iterative, tiered approach with respect to test compounds, test systems, bioanalysis and systems analysis will be adopted to evaluate existing models and develop new models that can provide validated test systems with respect to the prediction of specific forms of DILI and further elucidation of mechanisms. The approach will encompass completely characterised cell lines, well-defined and physiologically stable hepatocytes, multi-cell type in vitro models including novel bioreactors, animal models and appropriate ex vivo human cell models. A systematic analysis of data and iteration at each stage will select the ‘best’ cell line, animal model or pathway for further investigation moving from simple systems to more complex models with reference to relevant clinical and preclinical data on the various forms of DILI. Triangulation of human, in vitro and animal data will provide a fundamental understanding of how drugs can harm the liver. It will then be possible to define the application of each particular novel test system in the context of drug development, and its use in the prediction of liabilities associated with the various forms of DILI that occur in man. Just as importantly, the project will define those models that are not appropriate as decision-making tools for the prediction of DILI in man.
The MIP-DILI consortium contains Key Opinion Leaders from academia, the biotechnology sector and the pharmaceutical industry in the fields of drug development, drug metabolism, drug toxicology, drug hypersensitivity, liver immunology, liver cell biology, pharmacogenetics, systems biology and clinical adverse drug reactions.
Campo scientifico
Invito a presentare proposte
IMI-JU-03-2010
Vedi altri progetti per questo bando
Meccanismo di finanziamento
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinatore
151 85 Sodertaelje
Svezia
Mostra sulla mappa
Partecipanti (27)
L69 7ZX Liverpool
Mostra sulla mappa
1081 HV Amsterdam
Mostra sulla mappa
17177 Stockholm
Mostra sulla mappa
Partecipazione conclusa
53127 Bonn
Mostra sulla mappa
6726 SZEGED
Mostra sulla mappa
35065 RENNES CEDEX
Mostra sulla mappa
1000 Bruxelles
Mostra sulla mappa
2311 EZ Leiden
Mostra sulla mappa
413 46 Göteborg
Mostra sulla mappa
67115 Plobsheim
Mostra sulla mappa
69120 Heidelberg
Mostra sulla mappa
79098 Freiburg
Mostra sulla mappa
Partecipazione conclusa
DD1 5JJ Dundee
Mostra sulla mappa
65205 Wiesbaden
Mostra sulla mappa
10154 New York
Mostra sulla mappa
TW89GS Brentford
Mostra sulla mappa
92284 Courbevoie
Mostra sulla mappa
2340 Beerse
Mostra sulla mappa
2500 Valby
Mostra sulla mappa
64293 Darmstadt
Mostra sulla mappa
02200 Espoo
Mostra sulla mappa
94250 GENTILLY
Mostra sulla mappa
1070 Bruxelles / Brussel
Mostra sulla mappa
3584 CS Utrecht
Mostra sulla mappa
LS11 5PS Leeds
Mostra sulla mappa
81675 Muenchen
Mostra sulla mappa
RG21 4FA Basingstoke
Mostra sulla mappa